Waters Corporation  today announced the launch of the BioResolvetm Protein A Affinity Columns with MaxPeaktm Premier Technology, providing precise titer measurements. This launch marks the first set ...

CDR-Life today announced the appointment of Pascal Touchon, DVM, MBA, to its Board of Directors. Dr. Touchon brings 40 years of international experience in the biopharmaceutical industry, with ...

Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus ...

The antibody PLT012 targets the fat transporter CD36 to restore immune responses in tumors, offering a new and promising ...

COVID-19 testing includes molecular (PCR), antigen (rapid), and antibody (serology) tests, each serving different ...

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Association of PD-L1 mRNA levels in plasma-derived exosomes with response to nivolumab and pembrolizumab in melanoma and NSCLC. This is an ASCO Meeting Abstract from the 2018 ASCO-SITC Clinical Immuno ...

Genmab says choosing to insource cell-line development helped them to improve the antibody titers they were achieving.

We are on track with IND enabling development of our lead multifunctional antibody targeting TROP2 for the treatment of non-small cell lung cancer and several other cancer indications.” Avidicure will ...

New research from COMy 2025 reveals a high rate of infections among people with relapsed or refractory multiple myeloma ...

To improve on the activity of traditional bivalent monotopic antibodies, the Sellers lab systematically generated biparatopic antibodies targeting distinct epitope pairs in FGFR2 ECD, and ...

Antibody-drug conjugates have emerged as one of the most popular treatment modalities for investment in recent years. Following Pfizer’s proposed move for Seagen, Ben Hargreaves tracked how the ...